HilleVax, Inc., (HLVX): Price and Financial Metrics
HLVX Price/Volume Stats
| Current price | $1.86 | 52-week high | $20.22 |
| Prev. close | $1.83 | 52-week low | $1.55 |
| Day low | $1.83 | Volume | 839,400 |
| Day high | $1.94 | Avg. volume | 419,062 |
| 50-day MA | $1.89 | Dividend yield | N/A |
| 200-day MA | $6.97 | Market Cap | 92.64M |
HLVX Stock Price Chart Interactive Chart >
HilleVax, Inc., (HLVX) Company Bio
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
HLVX Price Returns
| 1-mo | 2.20% |
| 3-mo | 3.33% |
| 6-mo | -86.15% |
| 1-year | -87.71% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -88.41% |
| 2023 | -4.06% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...